[Bromazepam against anxiety in psychiatric patients (author's transl)]
- PMID: 6124940
[Bromazepam against anxiety in psychiatric patients (author's transl)]
Abstract
In this study involving 30 hospital patients (23 inpatients and 7 out-patients) with neurosis or depressive syndrome, bromazepam 12 mg/24 hours in 2 or 3 divided doses proved effective in controlling anxiety symptoms. The results, as measured by the Hamilton scale, were satisfactory in two-thirds of the cases, notably in neurotic anxiety. Free-floating anxiety and somatic symptoms were relieved. Undesirable reactions consisted of daytime somnolence (5 cases), feeling of dizziness (1 case) and fatigue (1 case).
Similar articles
-
[Clinical trial of bromazepam. Thirty-four cases (author's transl)].Nouv Presse Med. 1982 May 13;11(22):1741-3. Nouv Presse Med. 1982. PMID: 6124948 French.
-
[Clinical trial of bromazepam in hospital psychiatry (author's transl)].Nouv Presse Med. 1982 May 13;11(22):1735-7. Nouv Presse Med. 1982. PMID: 6124946 French.
-
[Treatment of anxiety with bromazepam in clinical practice (author's transl)].Nouv Presse Med. 1982 May 13;11(22):1731-4. Nouv Presse Med. 1982. PMID: 6124945 French.
-
Mixed anxiety and depression: from theory to practice.J Clin Psychiatry. 1997;58 Suppl 8:27-34. J Clin Psychiatry. 1997. PMID: 9236733 Review.
-
Rapid diagnosis and treatment of anxiety and depression in primary care: the somatizing patient.J Fam Pract. 1994 Oct;39(4):373-8. J Fam Pract. 1994. PMID: 7931117 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical